210 related articles for article (PubMed ID: 23013414)
1. Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
J Pineal Res; 2013 May; 54(4):373-80. PubMed ID: 23013414
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic effects of melatonin in endothelial cell cultures.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
Microvasc Res; 2013 May; 87():25-33. PubMed ID: 23473980
[TBL] [Abstract][Full Text] [Related]
3. Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells.
González-González A; González A; Alonso-González C; Menéndez-Menéndez J; Martínez-Campa C; Cos S
Oncol Rep; 2018 Jan; 39(1):433-441. PubMed ID: 29115538
[TBL] [Abstract][Full Text] [Related]
4. Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
J Pineal Res; 2012 Apr; 52(3):282-90. PubMed ID: 22151118
[TBL] [Abstract][Full Text] [Related]
5. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression.
Cui P; Yu M; Peng X; Dong L; Yang Z
J Pineal Res; 2012 Mar; 52(2):236-43. PubMed ID: 21913973
[TBL] [Abstract][Full Text] [Related]
6. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
[TBL] [Abstract][Full Text] [Related]
7. Effects of human breast stromal cells on conjugated linoleic acid (CLA) modulated vascular endothelial growth factor-A (VEGF-A) expression in MCF-7 cells.
Wang LS; Huang YW; Sugimoto Y; Liu S; Chang HL; Ye W; Shu S; Lin YC
Anticancer Res; 2005; 25(6B):4061-8. PubMed ID: 16312046
[TBL] [Abstract][Full Text] [Related]
8. Melatonin modulates aromatase activity and expression in endothelial cells.
Alvarez-García V; González A; Martínez-Campa C; Alonso-González C; Cos S
Oncol Rep; 2013 May; 29(5):2058-64. PubMed ID: 23450505
[TBL] [Abstract][Full Text] [Related]
9. Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF.
González A; González-González A; Alonso-González C; Menéndez-Menéndez J; Martínez-Campa C; Cos S
Oncol Rep; 2017 Apr; 37(4):2433-2440. PubMed ID: 28259965
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
[TBL] [Abstract][Full Text] [Related]
11. Chemically modified tetracyclines inhibit VEGF secretion by breast cancer cell lines.
Kothari M; Simon SR
Cytokine; 2006 Aug; 35(3-4):115-25. PubMed ID: 16978872
[TBL] [Abstract][Full Text] [Related]
12. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
Shekhar MP; Werdell J; Tait L
Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
14. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
16. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
17. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
18. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
[TBL] [Abstract][Full Text] [Related]
20. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo.
Bergman Jungeström M; Thompson LU; Dabrosin C
Clin Cancer Res; 2007 Feb; 13(3):1061-7. PubMed ID: 17289903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
